Topiramate Tablet, Film Coated
Product Images NDC 55154-7142

5 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 55154-7142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula (Structure)

Structured Formula (Structure)
Chemical structure of topiramate, showing its molecular framework with functional groups including sulfamate and several oxygen-containing rings, consistent with the generic drug topiramate's molecular composition.*
FDA Label Image

Figure 1 Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure In Study 1 (087c12f7 E830 4d20 E063 6294a90a570b 00)

Figure 1 Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure In Study 1 (087c12f7 E830 4d20 E063 6294a90a570b 00)
A line graph showing cumulative rates for time to first seizure over 500 days. Two dose groups of topiramate are compared: 50 mg/day (solid line) and 400 mg/day (dashed line). The graph indicates lower cumulative seizure rates over time for the 400 mg/day group versus the 50 mg/day group.*
FDA Label Image

Figure 2 Reduction In 4-week Migraine Headache Frequency (studies 11 And 12 For Adults And Adolescents) (Figure 2)

Figure 2 Reduction In 4-week Migraine Headache Frequency (studies 11 And 12 For Adults And Adolescents) (Figure 2)
A bar graph comparing changes from baseline in average monthly migraine period rates between placebo and different daily dosages of topiramate (50 mg, 100 mg, 200 mg) across two studies. The y-axis shows change from baseline, with decreases seen at all doses of topiramate compared to placebo. Statistical significance is indicated for higher doses.*
FDA Label Image

25mg Bag Label (40052c1b 5558 373b E063 6394a90ad7d4 01)

25mg Bag Label (40052c1b 5558 373b E063 6394a90ad7d4 01)
Label for Topiramate tablets, USP 25 mg, in a unit dose package of 10 tablets. The label includes storage instructions, warnings about child resistance and packaging integrity, and dispensing directions for pharmacists. Distributed by American Health Packaging and Cardinal Health.*
FDA Label Image

100mg Bag Label (40052c1b 5558 373b E063 6394a90ad7d4 00)

100mg Bag Label (40052c1b 5558 373b E063 6394a90ad7d4 00)
Label for topiramate tablets, USP 100 mg, film-coated oral tablets. The package contains 10 tablets. The label includes storage instructions, a warning that the unit dose package is not child-resistant and intended for institutional use, and distribution information by Cardinal Health and American Health Packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.